| BSE: 524816 | Sector: Health care |
| NSE: NATCOPHARM | ISIN Code: INE987B01026 |
| BSE 11:55 | 19 Feb | 652.00 |
14.75 (2.31%) |
OPEN
645.75 |
HIGH
666.45 |
LOW
643.30 |
| NSE 11:49 | 19 Feb | 651.00 |
14.65 (2.30%) |
OPEN
638.35 |
HIGH
666.00 |
LOW
637.00 |
| OPEN | 645.75 |
| PREVIOUS CLOSE | 637.25 |
| VOLUME | 7991 |
| 52-Week high | 737.80 |
| 52-Week low | 482.00 |
| P/E | 23.89 |
| Mkt Cap.(Rs cr) | 11,870 |
| Buy Price | 651.05 |
| Buy Qty | 1.00 |
| Sell Price | 651.95 |
| Sell Qty | 2.00 |
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company's focus is primarily on niche therapeutic areas and complex products. The company sells its products in over 40 countries. FDF products are sold in the United States I...> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | V C Nannapaneni | ||||||
| Independent Director : | G S Murthy | ||||||
| Vice Chairman : | Rajeev Nannapaneni | ||||||
| Company Secretary : | M Adinarayana | ||||||
| Independent Director : | T V Rao | ||||||
| Independent Director : | D G Prasad | ||||||
| Independent Director : | Leelaa Digumarti | ||||||
| Director : | PSRK Prasad | ||||||
| Independent Director : | MUR Naidu | ||||||
| Director : | D Linga Rao | ||||||
| Director : | Sridhar Sankararaman | ||||||
| AUDITOR : | Walker Chandiok & Co LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs & Formln | ||||||
| HOUSE NAME : | Natco | ||||||
| Registered office | |||||||
| Natco House, Road No 2 Banjara Hills,Hyderabad,Telangana-500033 | |||||||
| Ph : 91-040-23547532 | |||||||
| WEBSITE : http://www.natcopharma.co.in | |||||||
| E-mail : investors@natcopharma.co.in | |||||||
